| Product Code: ETC9520178 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Pregabalin Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Pregabalin Market - Industry Life Cycle |
3.4 Suriname Pregabalin Market - Porter's Five Forces |
3.5 Suriname Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Suriname Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Suriname Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Suriname |
4.2.2 Growing awareness about the benefits of pregabalin in pain management |
4.2.3 Rising healthcare expenditure and improved access to healthcare facilities in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in Suriname |
4.3.2 Competition from alternative pain management therapies and generic pregabalin products |
4.3.3 Potential side effects and safety concerns associated with pregabalin usage |
5 Suriname Pregabalin Market Trends |
6 Suriname Pregabalin Market, By Types |
6.1 Suriname Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Suriname Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Suriname Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Suriname Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Suriname Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Suriname Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Suriname Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Suriname Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Suriname Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Suriname Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Suriname Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Suriname Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Suriname Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Pregabalin Market Import-Export Trade Statistics |
7.1 Suriname Pregabalin Market Export to Major Countries |
7.2 Suriname Pregabalin Market Imports from Major Countries |
8 Suriname Pregabalin Market Key Performance Indicators |
8.1 Average prescription rate of pregabalin by healthcare providers |
8.2 Patient adherence and compliance rate to pregabalin treatment |
8.3 Number of clinical trials and studies conducted on pregabalin efficacy and safety in Suriname |
9 Suriname Pregabalin Market - Opportunity Assessment |
9.1 Suriname Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Suriname Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Suriname Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Pregabalin Market - Competitive Landscape |
10.1 Suriname Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Suriname Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here